HYPR
Hyperfine, Inc.·Healthcare
1.61
3.313%(−0.06)
Market OpenLast Updated: — ET
52W L: $0.5852W H: $2.22
HYPR NEWS
gurufocus.com
1d ago
Hyperfine to Join Russell 2000® and Russell 3000® Indexes
[url="]Hyperfine, Inc.[/url] (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powere
businesswire.com
1d ago
Hyperfine to Join Russell 2000® and Russell 3000® Indexes
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine is expected to join broad-market Russell 3000® Index & small-cap Russell 2000® Index at the conclusion of June 2026 Russell Reconstitution.
businesswire.com
5d ago
Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments
GUILFORD, Conn.--(BUSINESS WIRE)--PRIME study results show bedside portable MRI cut order-to-scan time vs conventional MRI and identified critical ED findings.
seekingalpha.com
May 12
Hyperfine, Inc. (HYPR) Q1 2026 Earnings Call Transcript
Hyperfine, Inc. (HYPR) Q1 2026 Earnings Call Transcript
marketbeat.com
May 12
Hyperfine Q1 Earnings Call Highlights
Hyperfine NASDAQ: HYPR reported a sharp year-over-year increase in first-quarter revenue and reiterated its full-year 2026 outlook, as management pointed to continued adoption of its next-generation Swoop portable MRI system across hospitals, neurology offices and international markets.
zacks.com
May 12
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Beats Revenue Estimates
Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.09 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.12 per share a year ago.
